- Home
- / IDEAYA Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
IDEAYA Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$29.9
2024-10-29
Market Capitalization
$2.5 B
2024-10-29
Revenue
$218.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.5M | 27.9M | 50.9M | 23.4M | 7.0M | 218.7M | |||
| General and administrative expense | 2.1M | 4.7M | 10.0M | 15.2M | 20.1M | 23.9M | 28.3M | 39.3M | 63.3M |
| Operating expense total | 114.4M | 36.4M | 44.3M | 54.9M | 113.4M | 157.8M | 334.0M | 378.0M | |
| EBIT | (14.4M) | (36.4M) | (44.3M) | (35.3M) | (50.3M) | (62.5M) | (134.4M) | (327.0M) | (159.3M) |
| EBIT margin, % | -180.9% | -122.7% | -574.9% | -4671.1% | -72.8% | ||||
| Interest income | 150.0K | 2.0M | 2.3M | ||||||
| Interest expense | 69.0K | 25.0K | |||||||
| Net Income | (11.9M) | (34.3M) | (42.0M) | (34.5M) | (49.8M) | (58.7M) | (113.0M) | (274.5M) | (113.7M) |
| EPS | (1.4) | (2.0) | (3.4) | (1.3) |